RecallDepth
Class III Terminated

Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30

This recall has been terminated (originally issued August 6, 2014).

Company
Pfizer Inc.
Recall Initiated
June 19, 2014
Posted
August 6, 2014
Recall Number
D-1485-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
22,461 bottles
Firm Location
New York, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.

Distribution

Nationwide (Continental USA and Puerto Rico). A portion of the bulk lot was supplied to Pfizer Germany for packaging into blisters for non- USA market. One of these lots in Germany was placed in stability having acceptable results, therefore are not part of the recall scope. Only the product distributed within US/PR market (bottles) is in the scope of this recall.

Lot / Code Info

Lot # V130822; Exp 01/15

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class III Drug recalls